Cargando…
Anti-CD47 antibody eliminates bone tumors in rats
Bone tumor is a rare heterogeneous malignancy. Osteosarcoma is the most common bone tumor with no apparent underlying pathogenesis, and its peak incidence often occurs during puberty. The intensive application of chemotherapy rarely alters the poor prognosis of the patients in advanced stage. Despit...
Autores principales: | Fang, Shiqiang, Yin, Hainan, Song, Zhen, Li, Ruixin, Xie, Xuesheng, Gu, Zengquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923504/ https://www.ncbi.nlm.nih.gov/pubmed/31889797 http://dx.doi.org/10.1016/j.sjbs.2019.09.011 |
Ejemplares similares
-
CD47 prevents the elimination of diseased fibroblasts in scleroderma
por: Lerbs, Tristan, et al.
Publicado: (2020) -
Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies
por: Pietsch, E C, et al.
Publicado: (2017) -
In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity
por: Zhang, Bin, et al.
Publicado: (2022) -
CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016) -
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
por: Candas-Green, Demet, et al.
Publicado: (2020)